Filing Details
- Accession Number:
- 0001209191-21-029378
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-30 13:00:00
- Reporting Period:
- 2021-04-28
- Accepted Time:
- 2021-04-30 19:57:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1796280 | Oric Pharmaceuticals Inc. | ORIC | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1214133 | H Richard Scheller | C/O Oric Pharmaceuticals, Inc. 240 E. Grand Ave., 2Nd Floor South San Francisco CA 94080 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-04-28 | 200 | $25.11 | 49,600 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-04-30 | 100 | $25.19 | 49,500 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.